Gilead Raday - Chief Operating Officer at RedHill Biopharma Ltd.

Issuer-level insider activity

Role
Chief Operating Officer
Issuer ticker
RDHL on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by Gilead Raday since 20 Aug 2025

Reported holdings for Gilead Raday in RedHill Biopharma Ltd.

Form 4 holding Chief Operating Officer

RedHill Biopharma Ltd.

Security class
Ordinary Shares
Shares / value
218,780,000
Estimated value
Report date
10 Jul 2026
Price
Ownership
Direct
Form 4 holding Chief Operating Officer

RedHill Biopharma Ltd.

Security class
American Depositary Shares
Shares / value
104,130,000
Estimated value
Report date
10 Jul 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for Gilead Raday in RedHill Biopharma Ltd.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .